Table 3 Assessing routine immunization, malaria commodities and diagnostic capacity in health facilities, Sierra Leone, 2016–2021
Programmatic Area | Variable | Feb_2016 | July_2016 | May_2017 | Aug_2018 | Feb_2019 | Aug_2021 | End Line vs. Baseline | P-value |
|---|---|---|---|---|---|---|---|---|---|
(N = 71) n (%) | (N = 99) n (%) | (N = 101) n (%) | (N = 126) n (%) | (N = 139) n (%) | (N = 156) n (%) | Difference (95 CI) | |||
Vaccination | Health facilities providing routine Immunization Services | 65 (91.5) | 95 (96.0) | 96 (95.0) | 120 (95.2) | 135 (97.1) | 150 (96.2) | 4.7 (-1.5, 13.7) | 0.14 |
Health facilities with functional refrigerator†| 32 (49.2) | 70 (73.7) | 72 (75.0) | 71 (59.2) | 88 (65.2) | 100 (66.7) | 17.5 (3.3, 31.2) | 0.0157 | |
Health facilities with updated temperature monitoring chart††| 11 (34.4) | 16 (22.9) | 32 (44.4) | 29 (40.8) | 37 (42.0) | 81 (81) | 46.6 (27.2,62.0) | < 0.0001 | |
Health facilities with all required basic antigens available at the time of the assessment†| 31(47.7) | 55(57.9) | 60(62.5) | 86 (71.7) | 103 (76.3) | 125 (83.3) | 35.6 (21.9, 48.3) | < 0.0001 | |
Heath facilities with expired antigens†| 2 (3.1) | 3 (3.2) | 1 (1) | 1 (0.8) | 2 (1.5) | 2 (1.3) | 1.8 (-2.3, 9.3) | 0.37 | |
Health facilities with Vaccine Vial Monitor at stage three and four†| 14 (21.5) | 16 (16.8) | 14 (14.6) | 8 (6.7) | 9 (6.7) | 10 (6.7) | 14.8 (5.1, 26.6) | 0.002 | |
Malaria Commodities | Health facilities with 1st line anti-malaria drugs | 69 (97.2) | 96 (97.0) | 99 (98.0) | 120 (95.2) | 135 (97.1) | 120 (76.9) | 20.3 (11.2, 27.7) | 0.0002 |
Health Facilities with rapid diagnostic kits for diagnosis of malaria | 67 (94.4) | 89 (89.9) | 98 (97.0) | 120 (95.2) | 134 (96.4) | 119 (76.3) | 18.1 (8.1, 26.1) | 0.001 | |
Health facilities with insecticide treated nets | 55 (77.5) | 92 (92.9) | 97 (96.0) | 111 (88.1) | 132 (95.0) | 139 (89.1) | 11.6 (1.6, 23.3) | 0.0218 |